Notably, according to a recent press release, although the CR rate was higher in the combination arm, this did not reach statistical significance (33.3% vs. 22.4%; p = 0.13).
← all excerpts
Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia.
1
0.1300
0.1300